Acne Scrub

Description

This foaming acne scrub contains 2% salicylic acid as an active ingredient, designed to help combat breakouts. The formulation includes naturally derived grapefruit extract, contributing to its efficacy. The product is presented in a 4.2 oz (124 mL) container and features a pink grapefruit scent. It is comparable to Neutrogena® Oil Free Acne Wash Pink Grapefruit Foaming Scrub.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The product may be used up to twice daily. To administer, the healthcare professional should instruct the patient to wet their face thoroughly. The patient should then apply the product to their hands, add water, and work it into a lather. It is important to massage the lather gently onto the face. After massaging, the patient should rinse the face well with water.

Healthcare professionals should advise patients to avoid contact with the eyes. In the event of contact, it is essential to flush the eyes thoroughly with water.

Contraindications

There are no contraindications listed for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

For external use only. This product is intended solely for topical application and should not be ingested. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Skin irritation and dryness may be exacerbated when used concurrently with other topical acne medications. To minimize the risk of adverse effects, it is recommended that only one topical acne treatment be utilized at a time. Should irritation occur, discontinue use of all topical acne medications and consult a healthcare professional for further guidance.

Healthcare professionals should remain vigilant for signs of skin irritation in patients using this product, and appropriate monitoring should be conducted to ensure safe and effective use.

Side Effects

Patients should be aware that the product is intended for external use only. Adverse reactions associated with the use of this product may occur, although specific adverse reactions have not been detailed in the available data. It is important for patients to monitor for any unexpected effects and to consult healthcare professionals if they experience any adverse reactions during use.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Acne Scrub (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of Acne Scrub (salicylic acid gel) in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this medication to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

The safety of this product during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus. The use of salicylic acid during pregnancy may pose risks, and it is advised that pregnant patients avoid its use unless clearly needed.

Dosage modifications may be necessary for pregnant individuals; therefore, it is essential for healthcare providers to be consulted for guidance. Pregnant women should seek advice from their healthcare provider before using this product to ensure the safety and well-being of both the mother and the fetus.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and individualized patient assessment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to contact a poison control center or a medical toxicologist for guidance on specific management strategies tailored to the substance involved.

Documentation of the incident, including the amount ingested and the time of ingestion, is crucial for effective treatment and management.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed. It is crucial for patients to understand the potential risks associated with accidental ingestion.

Additionally, healthcare providers should inform patients about the likelihood of skin irritation and dryness when using this medication concurrently with other topical acne treatments. Patients should be counseled to use only one topical acne medication at a time to minimize the risk of irritation. This guidance is essential for ensuring the safe and effective use of the medication.

Storage and Handling

The product is supplied in a container that must be stored at room temperature. It is essential to protect the product from light exposure to maintain its integrity. The container should be kept tightly closed when not in use to prevent contamination and degradation. Additionally, the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically and may be used up to twice daily. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Acne Scrub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)